Quantcast
Home > Quotes > SPNE

SeaSpine Holdings Corporation Common Stock (SPNE) Quote & Summary Data

SPNE 
$13.99
*  
0.26
1.82%
Get SPNE Alerts
*Delayed - data as of May 21, 2019  -  Find a broker to begin trading SPNE now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    SPNE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
21
Today's High / Low
$ 14.48 / $ 13.72
Share Volume
76,279
50 Day Avg. Daily Volume
88,856
Previous Close
$ 14.25
52 Week High / Low
$ 20.75 / $ 11.16
Market Cap
264,377,004
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -2.16
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.42

Intraday Chart

Shares Traded

Share Volume:
76,279
50 Day Avg. Daily Volume:
88,856

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.16

Trading Range

The current last sale of $13.99 is 25.36% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 14.48 $ 20.75
 Low: $ 13.72 $ 11.16

Company Description (as filed with the SEC)

SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures.  ... More ...  



Risk Grade

Where does SPNE fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 14.32
Open Date:
May 21, 2019
Close Price:
$ 13.99
Close Date:
May 21, 2019


Consensus Recommendation

Analyst Info